Sinovac’s vaccine trial data suggest potential in building immunity against COVID | coronavirus outbreak News,The Indian Express

Sinovac’s vaccine trial data suggest potential in building immunity against COVID | coronavirus outbreak News,The Indian Express

Sinovac’s vaccine trial data suggest potential in building immunity against COVID

By: Bloomberg | Updated: June 14, 2020 at 10:09 am

The Beijing-based company’s vaccine, called CoronaVac, hasn’t caused severe side effects and more than 90% of people administered with the shot on a 14-day interval have induced neutralizing antibodies two weeks after inoculation, Sinovac said in a press release on Sunday.